OBJECTIVE: To characterize prescription and other medication use in a geographically and ethnically diverse cohort of women in their first pregnancy. METHODS: In a prospective, longitudinal cohort study of nulliparous women followed through pregnancy from the first trimester, medication use was chronicled longitudinally throughout pregnancy. Structured questions and aids were used to capture all medications taken as well as reasons they were taken. Total counts of all medications taken including number in each category and class were captured. Additionally, reasons the medications were taken were recorded. Trends in medications taken across pregnancy and in the first trimester were determined. RESULTS: Of the 9,546 study participants, 9,272 (97.1%) women took at least one medication during pregnancy with 9,139 (95.7%) taking a medication in the first trimester. Polypharmacy, defined as taking at least five medications, occurred in 2,915 (30.5%) women. Excluding vitamins, supplements, and vaccines, 73.4% of women took a medication during pregnancy with 55.1% taking one in the first trimester. The categories of drugs taken in pregnancy and in the first trimester include the following: gastrointestinal or antiemetic agents (34.3%, 19.5%), antibiotics (25.5%, 12.6%), and analgesics (23.7%, 15.6%, which includes 3.6%; 1.4% taking an opioid pain medication). CONCLUSION: In this geographically and ethnically diverse cohort of nulliparous pregnant women, medication use was nearly universal and polypharmacy was common. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, NCT01322529.
OBJECTIVE: To characterize prescription and other medication use in a geographically and ethnically diverse cohort of women in their first pregnancy. METHODS: In a prospective, longitudinal cohort study of nulliparous women followed through pregnancy from the first trimester, medication use was chronicled longitudinally throughout pregnancy. Structured questions and aids were used to capture all medications taken as well as reasons they were taken. Total counts of all medications taken including number in each category and class were captured. Additionally, reasons the medications were taken were recorded. Trends in medications taken across pregnancy and in the first trimester were determined. RESULTS: Of the 9,546 study participants, 9,272 (97.1%) women took at least one medication during pregnancy with 9,139 (95.7%) taking a medication in the first trimester. Polypharmacy, defined as taking at least five medications, occurred in 2,915 (30.5%) women. Excluding vitamins, supplements, and vaccines, 73.4% of women took a medication during pregnancy with 55.1% taking one in the first trimester. The categories of drugs taken in pregnancy and in the first trimester include the following: gastrointestinal or antiemetic agents (34.3%, 19.5%), antibiotics (25.5%, 12.6%), and analgesics (23.7%, 15.6%, which includes 3.6%; 1.4% taking an opioid pain medication). CONCLUSION: In this geographically and ethnically diverse cohort of nulliparous pregnant women, medication use was nearly universal and polypharmacy was common. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, NCT01322529.
Authors: Allen A Mitchell; Suzanne M Gilboa; Martha M Werler; Katherine E Kelley; Carol Louik; Sonia Hernández-Díaz Journal: Am J Obstet Gynecol Date: 2011-04-22 Impact factor: 8.661
Authors: Richard A Epstein; William V Bobo; Peter R Martin; James A Morrow; Wei Wang; Rameela Chandrasekhar; William O Cooper Journal: Ann Epidemiol Date: 2013-08 Impact factor: 3.797
Authors: Jerrie S Refuerzo; Sean C Blackwell; Robert J Sokol; Lorraine Lajeunesse; Katherine Firchau; Michael Kruger; Yoram Sorokin Journal: Am J Perinatol Date: 2005-08 Impact factor: 1.862
Authors: Euni Lee; Mary K Maneno; Leah Smith; Sheila R Weiss; Ilene H Zuckerman; Anthony K Wutoh; Zhenyi Xue Journal: Pharmacoepidemiol Drug Saf Date: 2006-08 Impact factor: 2.890
Authors: Charles W Schauberger; Emily J Newbury; Jean M Colburn; Mohammed Al-Hamadani Journal: Am J Obstet Gynecol Date: 2014-03-13 Impact factor: 8.661
Authors: Kristin Palmsten; Sonia Hernández-Díaz; Christina D Chambers; Helen Mogun; Sophia Lai; Todd P Gilmer; Krista F Huybrechts Journal: Obstet Gynecol Date: 2015-09 Impact factor: 7.661
Authors: Xiaomei I Liu; Jeremiah D Momper; Natella Rakhmanina; John N van den Anker; Dionna J Green; Gilbert J Burckart; Brookie M Best; Mark Mirochnick; Edmund V Capparelli; André Dallmann Journal: J Clin Pharmacol Date: 2019-09-06 Impact factor: 3.126
Authors: Yassaman Vafai; Edwina H Yeung; Rajeshwari Sundaram; Melissa M Smarr; Nicole Gerlanc; William A Grobman; Daniel Skupski; Edward K Chien; Stefanie N Hinkle; Roger B Newman; Deborah A Wing; Angela C Ranzini; Anthony Sciscione; Jagteshwar Grewal; Cuilin Zhang; Katherine L Grantz Journal: Am J Perinatol Date: 2020-10-08 Impact factor: 3.079
Authors: Lauren A Gimbel; Nathan R Blue; Amanda A Allshouse; Robert M Silver; Bruce Gimbel; William A Grobman; David M Haas; Hyagriv N Simhan; Brian M Mercer; Tamera Hatfield Journal: J Matern Fetal Neonatal Med Date: 2021-11-07
Authors: Vinoj H Sewberath Misser; Arti Shankar; Ashna Hindori-Mohangoo; Jeffrey Wickliffe; Maureen Lichtveld; Dennis R A Mans Journal: Adv Pharmacoepidemiol Drug Saf Date: 2021-09-20
Authors: David M Haas; Brianna Mahnke; Ziyi Yang; David Guise; Joanne Daggy; Hyagriv N Simhan; Robert M Silver; William A Grobman; Ronald J Wapner; Joshua Makhoul; Samuel Parry; Brian M Mercer; George R Saade Journal: Obstet Gynecol Date: 2020-06 Impact factor: 7.623